Martijn Kerkhofs

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 5

Top Topics

Endoplasmic Reticulum Stress

Cell Cycle Arrest

Induced Apoptosis

Chronic Lymphocytic Leukemia

Top Venues

Cellular and molecular life sciences : CMLS

Science (New York, N.Y.)

Cell death & disease

British journal of pharmacology

This page only lists publications with an associated author ORCID identifier.

Publications

Flore Sneyers, Martijn Kerkhofs, Femke Speelman-Rooms, Kirsten Welkenhuyzen, Rita La Rovere, Ahmed Shemy, Arnout Voet, Guy Eelen, Mieke Dewerchin, Stephen W G Tait, Bart Ghesquière, Martin D Bootman, Geert Bultynck
Intracellular BAPTA directly inhibits PFKFB3, thereby impeding mTORC1-driven Mcl-1 translation and killing MCL-1-addicted cancer cells. Cell death & disease 14 (9) (2023)
Monika Pichla, Flore Sneyers, Kinga B Stopa, Geert Bultynck, Martijn Kerkhofs
Dynamic control of mitochondria-associated membranes by kinases and phosphatases in health and disease. Cellular and molecular life sciences : CMLS 78 (19-20) (2021)
Martijn Kerkhofs, Tamara Vervloessem, Kinga B Stopa, Victoria M Smith, Meike Vogler, Geert Bultynck
DLBCL Cells with Acquired Resistance to Venetoclax Are Not Sensitized to BIRD-2 But Can Be Resensitized to Venetoclax through Bcl-XL Inhibition. Biomolecules 10 (7) (2020)
Jeonghan Kim, Rajeev Gupta, Luz P Blanco, Shutong Yang, Anna Shteinfer-Kuzmine, Kening Wang, Jun Zhu, Hee Eun Yoon, Xinghao Wang, Martijn Kerkhofs, Hyeog Kang, Alexandra L Brown, Sung-Jun Park, Xihui Xu, Eddy D Zandee van Rilland, Myung K Kim, Jeffrey I Cohen, Mariana J Kaplan, Varda Shoshan-Barmaz, Jay H Chung
VDAC oligomers form mitochondrial pores to release mtDNA fragments and promote lupus-like disease. Science (New York, N.Y.) 366 (6472) (2019)
Monika A Jakubowska, Martijn Kerkhofs, Claudio Martines, Dimitar G Efremov, Julia V Gerasimenko, Oleg V Gerasimenko, Ole H Petersen, Geert Bultynck, Tim Vervliet, Pawel E Ferdek
ABT-199 (Venetoclax), a BH3-mimetic Bcl-2 inhibitor, does not cause Ca2+ -signalling dysregulation or toxicity in pancreatic acinar cells. British journal of pharmacology 176 (22) (2018)